leiomyoma. Leiomyoma of uterus
Conditions
Interventions
Intervention 1: Intervention group: 0.5 mg cabergoline tablet (weekly orally, 0.5mg Dostinex tablets per week made in Italy with a generic code of 00562 for 3 months). Intervention 2: Control group: P
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Uterin bleeding and pelvic pain The size of the leiomyoma is between 3 and 8 cm Aged between 20-50 years
Exclusion criteria
Exclusion criteria: Post menopause Pedunculated myoma Use of Hormonal or lipid-lowering agents during the last 6 months History of cardiovascular disease, venous thromboembolism, diabetes mellitus, liver and kidney disorders, hypertension Other malignancies Need or desire for lyomioma surgery in the next 3 months Pregnancy and lactation Uncontrolled hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The size of leiomyoma. Timepoint: Before and 3 month after intervention. Method of measurement: Ulthrasonography.;Uterine bleeding. Timepoint: Before and 3 month after intervention. Method of measurement: The number of bleeding days as well as the number of pads used.;Side effects of medication. Timepoint: Before and 3 month after intervention. Method of measurement: check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Marzieh Vahid Dastjerdi
Tehran University of Medical Sciences
Outcome results
None listed